# Study for Patients Previously Treated in Avapritinib Clinical Trials

> **NCT04825574** · PHASE4 · COMPLETED · sponsor: **Blueprint Medicines Corporation** · enrollment: 2 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** Avapritinib

## Key facts

- **NCT ID:** NCT04825574
- **Lead sponsor:** Blueprint Medicines Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-21
- **Primary completion:** 2023-11-23
- **Final completion:** 2023-11-23
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2024-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04825574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04825574, "Study for Patients Previously Treated in Avapritinib Clinical Trials". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04825574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*